vs
徕博科（LH）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
徕博科的季度营收约是Roper Technologies的1.7倍（$3.5B vs $2.1B），Roper Technologies净利率更高（15.8% vs 7.9%，领先7.9%），Roper Technologies同比增速更快（11.3% vs 5.8%），Roper Technologies自由现金流更多（$507.0M vs $70.5M），过去两年Roper Technologies的营收复合增速更高（10.5% vs 4.8%）
徕博科（Labcorp）是全球领先的生命科学与诊断检测企业，面向医疗机构、制药企业和个人患者提供全面的临床检验服务、药物研发支持及医疗检测解决方案，依托先进科研经验与创新技术输出准确可落地的健康洞察，助力临床决策、加快新药研发，提升全球患者健康水平。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
LH vs ROP — 直观对比
营收规模更大
LH
是对方的1.7倍
$2.1B
营收增速更快
ROP
高出5.5%
5.8%
净利率更高
ROP
高出7.9%
7.9%
自由现金流更多
ROP
多$436.5M
$70.5M
两年增速更快
ROP
近两年复合增速
4.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.5B | $2.1B |
| 净利润 | $277.8M | $331.0M |
| 毛利率 | 28.7% | 69.4% |
| 营业利润率 | 10.8% | 27.2% |
| 净利率 | 7.9% | 15.8% |
| 营收同比 | 5.8% | 11.3% |
| 净利润同比 | 30.5% | 53.7% |
| 每股收益（稀释后） | $3.35 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LHROP
| Q1 26 | $3.5B | $2.1B | ||
| Q4 25 | $3.5B | $2.1B | ||
| Q3 25 | $3.6B | $2.0B | ||
| Q2 25 | $3.5B | $1.9B | ||
| Q1 25 | $3.3B | $1.9B | ||
| Q4 24 | $3.3B | $1.9B | ||
| Q3 24 | $3.3B | $1.8B | ||
| Q2 24 | $3.2B | $1.7B |
净利润LHROP
| Q1 26 | $277.8M | $331.0M | ||
| Q4 25 | $164.7M | $428.4M | ||
| Q3 25 | $261.1M | $398.5M | ||
| Q2 25 | $237.9M | $378.3M | ||
| Q1 25 | $212.8M | $331.1M | ||
| Q4 24 | $143.4M | $462.3M | ||
| Q3 24 | $169.3M | $367.9M | ||
| Q2 24 | $205.3M | $337.1M |
毛利率LHROP
| Q1 26 | 28.7% | 69.4% | ||
| Q4 25 | 28.2% | 69.5% | ||
| Q3 25 | 28.8% | 69.5% | ||
| Q2 25 | 29.7% | 69.2% | ||
| Q1 25 | 28.3% | 68.7% | ||
| Q4 24 | 26.9% | 68.3% | ||
| Q3 24 | 27.6% | 69.2% | ||
| Q2 24 | 28.8% | 69.5% |
营业利润率LHROP
| Q1 26 | 10.8% | 27.2% | ||
| Q4 25 | 7.6% | 28.6% | ||
| Q3 25 | 11.1% | 28.4% | ||
| Q2 25 | 11.2% | 28.2% | ||
| Q1 25 | 9.7% | 27.9% | ||
| Q4 24 | 6.5% | 28.0% | ||
| Q3 24 | 7.7% | 28.1% | ||
| Q2 24 | 9.2% | 28.8% |
净利率LHROP
| Q1 26 | 7.9% | 15.8% | ||
| Q4 25 | 4.7% | 20.8% | ||
| Q3 25 | 7.3% | 19.8% | ||
| Q2 25 | 6.7% | 19.5% | ||
| Q1 25 | 6.4% | 17.6% | ||
| Q4 24 | 4.3% | 24.6% | ||
| Q3 24 | 5.2% | 20.8% | ||
| Q2 24 | 6.4% | 19.6% |
每股收益（稀释后）LHROP
| Q1 26 | $3.35 | $4.87 | ||
| Q4 25 | $1.98 | $3.97 | ||
| Q3 25 | $3.12 | $3.68 | ||
| Q2 25 | $2.84 | $3.49 | ||
| Q1 25 | $2.52 | $3.06 | ||
| Q4 24 | $1.72 | $4.29 | ||
| Q3 24 | $2.00 | $3.40 | ||
| Q2 24 | $2.43 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $981.1M | $382.9M |
| 总债务越低越好 | $5.8B | $9.7B |
| 股东权益账面价值 | $8.7B | $18.8B |
| 总资产 | $19.1B | $34.6B |
| 负债/权益比越低杠杆越低 | 0.67× | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资LHROP
| Q1 26 | $981.1M | $382.9M | ||
| Q4 25 | $532.3M | $297.4M | ||
| Q3 25 | $598.1M | $320.0M | ||
| Q2 25 | $647.3M | $242.4M | ||
| Q1 25 | $369.4M | $372.8M | ||
| Q4 24 | $1.5B | $188.2M | ||
| Q3 24 | $1.5B | $269.6M | ||
| Q2 24 | $265.1M | $251.5M |
总债务LHROP
| Q1 26 | $5.8B | $9.7B | ||
| Q4 25 | — | $9.3B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益LHROP
| Q1 26 | $8.7B | $18.8B | ||
| Q4 25 | $8.6B | $19.9B | ||
| Q3 25 | $8.7B | $20.0B | ||
| Q2 25 | $8.5B | $19.6B | ||
| Q1 25 | $8.3B | $19.2B | ||
| Q4 24 | $8.1B | $18.9B | ||
| Q3 24 | $8.2B | $18.5B | ||
| Q2 24 | $8.0B | $18.1B |
总资产LHROP
| Q1 26 | $19.1B | $34.6B | ||
| Q4 25 | $18.4B | $34.6B | ||
| Q3 25 | $18.3B | $34.6B | ||
| Q2 25 | $18.1B | $33.2B | ||
| Q1 25 | $17.6B | $31.4B | ||
| Q4 24 | $18.4B | $31.3B | ||
| Q3 24 | $18.6B | $31.6B | ||
| Q2 24 | $16.7B | $29.8B |
负债/权益比LHROP
| Q1 26 | 0.67× | 0.52× | ||
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $191.5M | — |
| 自由现金流经营现金流 - 资本支出 | $70.5M | $507.0M |
| 自由现金流率自由现金流/营收 | 2.0% | 24.2% |
| 资本支出强度资本支出/营收 | 3.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.69× | — |
| 过去12个月自由现金流最近4个季度 | $1.4B | — |
8季度趋势，按日历期对齐
经营现金流LHROP
| Q1 26 | $191.5M | — | ||
| Q4 25 | $614.2M | $738.0M | ||
| Q3 25 | $387.2M | $869.5M | ||
| Q2 25 | $620.6M | $404.1M | ||
| Q1 25 | $18.5M | $528.7M | ||
| Q4 24 | $777.2M | $722.2M | ||
| Q3 24 | $277.3M | $755.4M | ||
| Q2 24 | $561.1M | $384.1M |
自由现金流LHROP
| Q1 26 | $70.5M | $507.0M | ||
| Q4 25 | $490.3M | — | ||
| Q3 25 | $280.5M | — | ||
| Q2 25 | $542.7M | — | ||
| Q1 25 | $-107.5M | — | ||
| Q4 24 | $665.1M | — | ||
| Q3 24 | $161.5M | — | ||
| Q2 24 | $432.9M | — |
自由现金流率LHROP
| Q1 26 | 2.0% | 24.2% | ||
| Q4 25 | 13.9% | — | ||
| Q3 25 | 7.9% | — | ||
| Q2 25 | 15.4% | — | ||
| Q1 25 | -3.2% | — | ||
| Q4 24 | 20.0% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 13.4% | — |
资本支出强度LHROP
| Q1 26 | 3.4% | 0.5% | ||
| Q4 25 | 3.5% | — | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 3.8% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 3.5% | — | ||
| Q2 24 | 4.0% | — |
现金转化率LHROP
| Q1 26 | 0.69× | — | ||
| Q4 25 | 3.73× | 1.72× | ||
| Q3 25 | 1.48× | 2.18× | ||
| Q2 25 | 2.61× | 1.07× | ||
| Q1 25 | 0.09× | 1.60× | ||
| Q4 24 | 5.42× | 1.56× | ||
| Q3 24 | 1.64× | 2.05× | ||
| Q2 24 | 2.73× | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LH
| Revenues | $2.8B | 78% |
| Other | $775.5M | 22% |
ROP
暂无分部数据
